Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 510

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

Open access
Wrensch, Margaret, Jenkins, Robert B, Chang, Jeffrey S, Yeh, Ru-Fang, Xiao, Yuanyuan, Decker, Paul A, Ballman, Karla V, Berger, Mitchel, Buckner, Jan C, Chang, Susan, Giannini, Caterina, Halder, Chandralekha, Kollmeyer, Thomas M, Kosel, Matthew L, LaChance, Daniel H, McCoy, Lucie, O'Neill, Brian P, Patoka, Joe, Pico, Alexander R, Prados, Michael, Quesenberry, Charles, Rice, Terri, Rynearson, Amanda L, Smirnov, Ivan, Tihan, Tarik, Wiemels, Joe, Yang, Ping, Wiencke, John K·2009·Nature Genetics
DOI 10.1038/ng.408
Open this paper in CoChat — free account

Abstract

The causes of glioblastoma and other gliomas remain obscure. To discover new candidate genes influencing glioma susceptibility, we conducted a principal component–adjusted genome-wide association study (GWAS) of 275,895 autosomal variants among 692 adult high-grade glioma cases (622 from the San Francisco Adult Glioma Study (AGS) and 70 from the Cancer Genome Atlas (TCGA)) and 3,992 controls (602 from AGS and 3,390 from Illumina iControlDB (iControls)). For replication, we analyzed the 13 SNPs with P < 10−6 using independent data from 176 high-grade glioma cases and 174 controls from the Mayo Clinic. On 9p21, rs1412829 near CDKN2B had discovery P = 3.4 × 10−8, replication P = 0.0038 and combined P = 1.85 × 10−10. On 20q13.3, rs6010620 intronic to RTEL1 had discovery P = 1.5 × 10−7, replication P = 0.00035 and combined P = 3.40 × 10−9. For both SNPs, the direction of association was the same in discovery and replication phases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.408

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 21

  1. Schwartzbaum, J.A., Fisher, J.L., Aldape, K.D. & Wrensch, M. Epidemiology and molecular pathology of glioma. Nat. Clin. Pract. Neurol. 2, 494–503 (2006). · DOI · Paper page
  2. Bahuau, M. et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res. 58, 2298–2303 (1998).
  3. Krimpenfort, P. et al. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448, 943–946 (2007). · DOI · Paper page
  4. Fuxe, J. et al. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ. 11, 373–384 (2000).
  5. Seoane, J. et al. TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3, 400–408 (2001). · DOI · Paper page
  6. Lemmens, R. et al. Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke. Eur. J. Hum. Genet. advance online publication, doi:10.1038/ejhg.2009.42 (25 March 2009). · DOI
  7. Mohlke, K.L., Boehnke, M. & Abecasis, G.R. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Hum. Mol. Genet. 17, R102–R108 (2008). · DOI
  8. Schaefer, A.S. et al. Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet. 5, e1000378 (2009). · DOI
  9. Schunkert, H. et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117, 1675–1684 (2008). · DOI · Paper page
  10. Shervington, A. et al. Glioma: what is the role of c-Myc, hsp90 and telomerase? Mol. Cell. Biochem. 283, 1–9 (2006). · DOI
  11. Maes, L. et al. Relation between telomerase activity, hTERT and telomere length for intracranial tumours. Oncol. Rep. 18, 1571–1576 (2007).
  12. Falchetti, M.L. et al. Telomerase inhibition impairs tumor growth in glioblastoma xenografts. Neurol. Res. 28, 532–537 (2006). · DOI
  13. Mushiroda, T. et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 45, 654–656 (2008). · DOI
  14. McKay, J.D. et al. Lung cancer susceptibility locus at 5p15.33. Nat. Genet. 40, 1404–1406 (2008). · DOI · Paper page
  15. Felini, M.J. et al. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20, 87–96 (2009). · DOI
  16. Wrensch, M. et al. Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin. Cancer Res. 13, 197–205 (2007). · DOI
  17. Davis, F.G. et al. Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol. Biomarkers Prev. 17, 484–489 (2008). · DOI
  18. Pico, A.R. et al. SNPLogic: an interactive single nucleotide polymorphism selection, annotation, and prioritization system. Nucleic Acids Res. 37, D803–D809 (2009). · DOI
  19. Dausset, J. et al. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 6, 575–577 (1990). · DOI · Paper page
  20. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005). · DOI · Paper page
  21. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. & Poland, G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70, 425–434 (2002). · DOI

Cited by

See all 510

Metadata

Authors
Wrensch, M., Jenkins, R. B., Chang, J. S., Yeh, R.-F., Xiao, Y., Decker, P. A., Ballman, K. V., Berger, M., Buckner, J. C., Chang, S., Giannini, C., Halder, C., Kollmeyer, T. M., Kosel, M. L., LaChance, D. H., McCoy, L., O'Neill, B. P., Patoka, J., Pico, A. R., Prados, M., Quesenberry, C., Rice, T., Rynearson, A. L., Smirnov, I., Tihan, T., Wiemels, J., Yang, P., & Wiencke, J. K.
Venue
Nature Genetics
Publisher
Springer Science and Business Media LLC
Published
2009-07-05
Volume
41
Issue
8
Pages
905-908
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
DOI
10.1038/ng.408
OpenAlex
W2133980633
Cited by
510
References
6
FWCI
23.87
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. https://app.cochat.ai/papers/10.1038/ng.408
The paper
Wrensch, M., Jenkins, R. B., Chang, J. S., Yeh, R.-F., Xiao, Y., Decker, P. A., Ballman, K. V., Berger, M., Buckner, J. C., Chang, S., Giannini, C., Halder, C., Kollmeyer, T. M., Kosel, M. L., LaChance, D. H., McCoy, L., O'Neill, B. P., Patoka, J., Pico, A. R., . . . Wiencke, J. K. (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nature Genetics. https://doi.org/10.1038/ng.408

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.